BIOLOGY OF THE HUMAN GLYCOPHORIN BLOOD GROUP ANTIGENS
BIOLOGY OF THE HUMAN GLYCOPHORIN BLOOD GROUP ANTIGENS
批准号:
6110496
负责人:
STEPHEN SPITALNIK
金额:
$40.59万
依托单位国家:
美国
项目类别:
财政年份:
1999
资助国家:
美国
项目状态:
已结题
起止时间:
1999-01-01 至 1999-12-31
关键词:
CHO cells Plasmodium falciparum antibody specificity blood group antigens glycophorin glycosylation human tissue immunity intracellular transport laboratory mouse microorganism immunology monoclonal antibody receptor binding receptor expression recombinant proteins site directed mutagenesis transfection
中文摘要
血型糖蛋白 A 是人类红细胞表面的主要糖蛋白
并含有一个N-聚糖和多个O-聚糖。 血型糖蛋白B,一种高度
人红细胞上的同源糖蛋白,仅含有 O-聚糖。
尽管适当的糖基化对于细胞表面表达至关重要
血型糖蛋白 A,造成这种作用的机制不是
明白了。 血型糖蛋白 A 和 B 在实践中很重要
输血医学,因为它们携带多种人类血型抗原,
这些抗原的抗体会引起溶血性输血反应,
新生儿溶血病和自身免疫性溶血性贫血。
然而,很少有研究检验其精细特异性。
人多克隆和小鼠单克隆抗体与这些抗体的结合
分子。 血型糖蛋白 A 和 B 也具有医学重要性,因为
它们作为疟原虫入侵的红细胞表面受体
恶性疟原虫裂殖子。 由于突变体获得难度大
具有确定的氨基酸序列变异的血型糖蛋白分子和
寡糖结构,详细了解这种宿主细胞——
寄生虫相互作用尚不可用。 当前的目标
建议研究细胞生物学、免疫学和受体功能
人类血型血型糖蛋白抗原的检测方法:
1.确定N-聚糖和O-聚糖在其中所起的作用
血型糖蛋白 A 的细胞内转运。
2. 使用重组DNA方法检查小鼠和人类的免疫
对血型糖蛋白 A 和 B 的反应,以及
3.测定血型糖蛋白A的肽和碳水化合物部分和
B 被人类疟疾寄生虫识别。
这些目标将通过使用一系列稳定转染的细胞来实现
表达野生型或变体血型糖蛋白 A 或 B 的 cDNA 的品系。 新
突变型糖蛋白 A 和 B cDNA 将通过定点构建
诱变。 B=y 在正常中国仓鼠卵巢中表达 cDNA
成纤维细胞和糖基化缺陷的细胞,有可能
创建氨基酸和氨基酸不同的变体糖蛋白
碳水化合物序列。 将构建噬菌体展示库
检查小鼠对血型糖蛋白 A 的免疫反应。这将确定
免疫反应是否受到限制也会导致过敏
构建新型临床有用的血清学试剂。 总而言之,
这些研究将加深对细胞生物学的了解,
免疫学以及血型糖蛋白 A 和 B 的受体功能。
英文摘要
Glycophorin A is the major glycoprotein on the human erythrocyte surface
and contains one N-glycan and multiple O-glycans. Glycophorin B, a highly
homologous glycoprotein on human erythrocytes, contains only O-glycans.
Although appropriate glycosylation is crucial for cell surface expression
of glycophorin A, the mechanism responsible for this effect is not
understood. Glycophorin A and B are important in the practice of
transfusion medicine since they carry multiple human blood group antigens,
and antibodies to these antigens can cause hemolytic transfusion reactions,
hemolytic disease of the newborn,a nd autoimmune hemolytic anemia.
However, there have been few studies examining the fine specificity of
binding of human polyclonal and mouse monoclonal antibodies to these
molecules. Glycophorins A and B are also of medical importance because
they serve as erythrocyte surface receptors for the invasion of Plasmodium
falciparum malaria merozoites. Due to the difficulty in obtaining mutant
glycophorin molecules with defined variaitons in amino acid sequence and
oligosaccharide structure, a detailed understanding of this host cell-
parasite interaction is not yet available. The goals of the current
proposal are to study the cell biology, immunology, and receptor function
of the human blood group glycophorin antigens by:
1. determining the role that the N-glycans and O-glycans play in
intracellular transport of glycophorin A.
2. using recombinant DNA approaches to examine the murine and human immune
response to glycophorins A and B, and
3. determining the peptide and carbohydrate portions of glycophorins A and
B that are recognized by human malaria parasites.
These goals will be achieved by using a series of stably transfected cell
lines expressing cDNA of wild type or variant glycophorin A or B. New
mutant glycophorin A and B cDNAs will be constructed by site-directed
mutagenesis. B=y expressing the cDNAs in both normal Chinese hamster ovary
fibroblasts and those with defects in glycosylation, it is possible to
create variant glycophorins that differ in both amino acid and
carbohydrate sequence. Phage display libraries will be constructed to
examine the murine immune response to glycophorin A. This will determine
whether the immune response is restricted and will also result in athe
construction of new clinically useful serological reagents. In summary,
these studies will result in greater understanding of the cell biology,
immunology, and receptor function of glycophorins A and B.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
BIOLOGY OF THE HUMAN GLYCOPHORIN BLOOD GROUP ANTIGENS
-
批准号:6302368
-
项目类别:
-
资助金额:$40.59万
-
财政年份:2000
-
负责人:STEPHEN SPITALNIK
-
依托单位:
BIOLOGY OF THE HUMAN GLYCOPHORIN BLOOD GROUP ANTIGENS
-
批准号:6273080
-
项目类别:
-
资助金额:$38.64万
-
财政年份:1998
-
负责人:STEPHEN SPITALNIK
-
依托单位:
BIOLOGY OF THE HUMAN GLYCOPHORIN BLOOD GROUP ANTIGENS
-
批准号:6242490
-
项目类别:
-
资助金额:$35.52万
-
财政年份:1997
-
负责人:STEPHEN SPITALNIK
-
依托单位:
BIOLOGY OF THE HUMAN GLYCOPHORIN BLOOD GROUP ANTIGENS
-
批准号:5214315
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:STEPHEN SPITALNIK
-
依托单位:--
海外基金